Gilead takes heat: Waxman ignites debate on drugs
March 21, 2014 at 12:30 PM EDT
Biotech stocks drop on reports Rep. Henry Waxman has sent a letter to Gilead's CEO asking him to justify the price of Hepatitis C drug Sovaldi.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.